Tuesday, May 21, 2019 Daily Archives

Evotec lays down $90m to buy Just for kickstarting biologics biz

by

German services firm Evotec has jumped into the biologics development space through the acquisition of Just.Bio, a platform company working to reduce the cost of goods for proteins. Hamburg, Germany-based Evotec uses its expertise and technologies to help pharma firms discover and develop new small molecule therapies and names Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, and UCB among its partners. Through the addition of Just.Bio for $90 million (€81 million) cash, Evotec has increased its…

May 21, 2019

German Merck: Continuous is key for bioprocess future

by

Merck KGaA reports a 15% year-on-year growth in its Process Solutions business and looks to its next-generation bioprocessing platform BioContinuum to continue the momentum. For the first quarter 2019, Germany’s Merck saw net sales within its life science business of €1.7 billion ($1.9 billion), up from €1.5 billion in the same period last year. The firm’s Process Solutions unit – which includes MilliporeSigma – however, saw a 15.1% year-on-year growth driven by bioprocessing demand, equating to €700 million. Merck’s results…

May 21, 2019